Alina Zamoshnikova

 

Alina Zamoshnikova

 

PhD Student, Inflammasome Lab

 

 

Alina completed her Bachelors and Masters degrees in Kyiv, Ukraine, specialising in biochemistry and molecular biology. Her interest in cell signalling brought her to Professor Svetlana Sidorenko’s lab where her BSc research project focused on CD150-mediated signalling in B cells. Her MSc research involved characterising a new receptor, FcR-like 6, found on the surface of T cells. After her MSc studies, Alina applied her understanding of the adaptive immune responses by working in the R&D group of a biotech start-up company, developing ELISA-based diagnostic kits for human infectious diseases. In 2012, Alina commenced her PhD in the Inflammasome Lab, switching to innate immunity and inflammation research. She is currently writing her thesis that focuses on the molecular and functional characterisation of NLRP12.

 

Working in the Inflammasome Lab has been a great experience. It is a fantastic team of people, passionate about their research, very supportive and generous in sharing their expertise.

 

CONTACTS AND LINKS


 

Email: a.zamoshnikova@imb.uq.edu.au

Office Telephone: +61 7 3346 2351

Other Telephone: +61 7 3346 2356

 

Research Gate

 

AWARDS AND PUBLICATIONS


 

 

AWARDS, GRANTS AND PRIZES

 

2012 International Postgraduate Research Scholarship

 

2012 University of Queensland Centennial Scholarship

 

EDUCATION

 

2010 MSc in Biochemistry/Molecular Biology, Taras Shevchenko National University of Kyiv, Ukraine

 

2008 BSc in Biology, Taras Shevchenko National University of Kyiv, Ukraine

 

 

ORIGINAL RESEARCH ARTICLES

 

Sester DP, Zamoshnikova A, Thygesen SJ, Vajjhala PR, Cridland SO, Schroder K, Stacey KJ. (2016).
Assessment of inflammasome formation by flow cytometry. Current Protocols In press.

 

Zamoshnikova A, Groß CJ, Schuster S, Chen KW, Wilson A, Tacchini-Cottier F, Schroder K (2016).
NLRP12 is a neutrophil-specific, negative regulator of in vitro cell migration but does not modulate LPS- or infection-induced NF-κB or ERK signalling. Immunobiology 221(2):341-6. Pubmed

 

Schroder K, Sagulenko V, Zamoshnikova A, Richards AA, Cridland JA, Irvine KM, Stacey KJ, Sweet MJ (2012).
Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction. Immunobiology 217: 1325-1329. Pubmed

 

REVIEWS AND BOOK CHAPTERS

 

Chen KW, Richards AA, Zamoshnikova A, Schroder K (2014).
Inflammasomes and inflammation. Chapter 8 in Cancer and Inflammation Mechanisms, Y. Hiraku, S. Kawanishi, H. Ohshima (Editors). (USA: John Wiley and Sons, Inc). Wiley

 

 

Kulemzin SV, Zamoshnikova AY, Yurchenko MY, Vitak NY, Najakshin AM, Fayngerts SA, Chikaev NA, Reshetnikova ES, Kashirina NM, Peclo MM, Rutkevich PN, Shevelev AY, Yanushevskaya EV, Baranov KO, Mamonkin M, Vlasik TN, Sidorenko SP, Taranin AV, Mechetina LV (2011).
FCRL6 receptor: expression and associated proteins. Immunology Letters 34(2):174-82.

 

Yurchenko M, Shlapatska LM, Romanets OL, Ganshevskiy D, Kashuba E, Zamoshnikova A, Ushenin YV, Snopok BA, Sidorenko SP (2011).
CD150-mediated Akt signalling pathway in normal and malignant B cells. Experimental Oncology 33(1):9-18.